QualityStocksNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Breakthrough in Liquid Biopsy With Over 99% Cancer DNA Purity
VolitionRx (NYSE American: VNRX) announced a breakthrough in liquid biopsy technology, achieving over 99% purity in isolating circulating tumor-derived DNA…